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Introduction

Thick Slice CLARITY

Current methods of intact tissue structural analysis
are incompatible with most methods of molecular
phenotyping, leading to difficulty in gaining a
perspective on a tissue which includes both its
structural and molecular level information.

Because of the inherent limitations of thin slice
immunohistochemistry (IHC) methods and the
cost, both financially and in terms of time, of whole
organ/body CLARITY, Xiaochen Lu developed
Thick Slice CLARITY in the lab of Lisa Stubbs at
the Carl R. Woese Institute for Genomic Biology at
the University of Illinois at Urbana-Champaign.

The barrier to the visualization of intact systems is
the lipid bilayers in biological tissues, which hinder
our molecular probing and limit our ability to image
the tissue by rendering the tissue opaque.1
Removing them is challenging because of their
importance for the structural integrity of the tissue.
The CLARITY technique is a tissue clearing
method to allow for both structural and
molecular analysis of a tissue sample. By
attaching the biomolecules within a sample to a
hydrogel matrix, we preserve the tissue’s
structure. From there, the unattached lipids can be
drained, making the tissue optically transparent.1

Fig. 1, Above, a mouse brain before and after CLARITY technique,
by K. Chung and K. Deisseroth, Howard Hughes Medical Institute/Stanford

The now transparent tissue is permeable to light
and macromolecules, and is able to undergo
immunostaining and 3D imaging.
Unfortunately, whole tissue or whole body
CLARITY is very expensive and time
consuming, taking weeks or months to complete
the process, limiting the efficiency of work that can
be done.

Thick Slice CLARITY takes the clearing and
antibody staining principles of whole organ
CLARITY and applies it instead to 200μm thick
slices of brain tissue.
Fig. 2, Right, GPR3 (in
green) co-located with
neurons (NeuN, in red) in a
200 micron thick slice of
mouse brain.
This image was taken using
a Zeiss LSM 700 confocal
microscope after Thick Slice
CLARITY techniques and
antibody staining had been
applied to the brain slices.

After a transcardial perfusion, mouse brains are
extracted and fixed in a
paraformaldehyde/acrylamide solution. The
brains are then sectioned on a vibrating
microtome, and the slices incubated at 37oC for
three hours, and then polymerized at 37oC for
three hours. For Thick Slice CLARITY, rather
than doing clearing by electrophoretic tissue
clearing (ETC) methods, passive clearing over
the course of two to three days in SDS-ETC
solution at 37oC is more typical. After the lipids
have been cleared from the tissue, the slices
may undergo multiple rounds of antibody
staining, and then may be mounted and
imaged, generally via confocal microscopy.
Thick Slice CLARITY allows for the viewing of
regional sections of the brain and analysis at a
structural and molecular level. It has proven
very useful for the localization of novel
neuroactive target gene products.

Current Work
Recent research into mouse activity and
exercise showed that there is a strong positive
correlation between the expression levels of
Gpr3, a gene encoding an orphan G-proteincoupled receptor involved in signal
transduction, and motivation for voluntary
running activity in mice.3 Because of its density
of dopamine receptors, the striatum was
identified as a
brain region likely to
have experienced
changes at a
molecular level as a
result of changed
intrinsic exercise
motivation.
The Thick Slice
CLARITY
3 Above, GPR3 (in green) co-located
technique, used in Fig.with
neurons, identified using the panneuronal marker NeuN (in red).
conjunction with
standard fluorescent staining methods and
imaging via confocal microscopy, has allowed
for the colocalization of GPR3 with neurons in
the mouse striatum, verifying the hypothesis of
the area’s importance. As seen on in Fig. 3, the
small number of cells labeled with GPR3
reinforces standing ideas of where Gpr3 is
expressed.
Similar techniques were employed to localize
NR2F1, the product of a deeply conserved autism
gene, in neurons in the brain. While previously
known to be existent in the human brain, its
localization was unknown.
It is important to
note that NR2F1
expression, in
green, is localized
only in neurons, in
red, and not in
other cell types,
such as glia, in
blue. This
distinction is
important for work
Fig 4., Above, NR2F1 (in green) localized in
neurons, identified with the pan-neuronal
into the future.
marker NeuN (in red) and cell nuclei. .

Future Work
The localization of GPR3 with the CLARITY
technique has made future work on the
exercise project actionable. It will lead to
further localization and other efforts, and
contribute to research into the possibility of
the use of pharmacological compounds to
increase voluntary exercise motivation.
The localization of NR2F1 in neurons was a
step towards understanding its position in
the brain, and will contribute to research
involved in autism and other developmental
disabilities.
CLARITY itself is a fairly new technique with
a lot of potential, both seen and unseen, for
future purposes. The technique has
potential for mapping neural circuits and
other connectomics work, for classifying
and subclassifying neurons, and for
protein localization in other projects.
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